BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janse IC, Koldijk MJ, Spekhorst LM, Vila AV, Weersma RK, Dijkstra G, Horváth B. Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:106-113. [PMID: 26422515 DOI: 10.1097/mib.0000000000000579] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Hung YT, Le PH, Kuo CJ, Tang YC, Chiou MJ, Chiu CT, Kuo CF, Huang YH. The Temporal Relationships and Associations between Cutaneous Manifestations and Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study. J Clin Med 2021;10:1311. [PMID: 33810197 DOI: 10.3390/jcm10061311] [Reference Citation Analysis]
2 Gorenjak M, Zupin M, Jezernik G, Skok P, Potočnik U. Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. Sci Rep 2021;11:5449. [PMID: 33750834 DOI: 10.1038/s41598-021-84909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dumont L, Landman C, Sokol H, Beaugerie L, Cosnes J, Seksik P, Guégan S; CD-HS Study Group. Increased risk of permanent stoma in Crohn’s disease associated with hidradenitis suppurativa: a case-control study. Aliment Pharmacol Ther 2020;52:303-10. [DOI: 10.1111/apt.15863] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Jfri A, Charrow A. Risk factors associated with hidradenitis suppurativa comorbid with inflammatory bowel disease and clinical phenotypes: a pilot case-control study. Int J Dermatol 2022. [PMID: 35722935 DOI: 10.1111/ijd.16311] [Reference Citation Analysis]
5 Principi M, Cassano N, Contaldo A, Iannone A, Losurdo G, Barone M, Mastrolonardo M, Vena GA, Ierardi E, Di Leo A. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol 2016; 22(20): 4802-4811 [PMID: 27239107 DOI: 10.3748/wjg.v22.i20.4802] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
6 Jansen FM, Vavricka SR, den Broeder AA, de Jong EM, Hoentjen F, van Dop WA. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterol J 2020;8:1031-44. [PMID: 32921269 DOI: 10.1177/2050640620958902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
7 Garg A, Hundal J, Strunk A. Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States. JAMA Dermatol. 2018;154:814-818. [PMID: 29800049 DOI: 10.1001/jamadermatol.2018.0878] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
8 Zhang M, Chen QD, Xu HX, Xu YM, Chen HJ, Yang BL. Association of hidradenitis suppurativa with Crohn’s disease. World J Clin Cases 2021; 9(15): 3506-3516 [PMID: 34046451 DOI: 10.12998/wjcc.v9.i15.3506] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tandon P, Govardhanam V, Gallinger Z, Weizman AV. Risk Factors for Developing Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Retrospective Case-Control Study. J Can Assoc Gastroenterol 2021;4:165-72. [PMID: 34337316 DOI: 10.1093/jcag/gwaa024] [Reference Citation Analysis]
10 Pavlis J, Miteva M. SnapshotDx Quiz: May 2017. J Invest Dermatol 2017;137:e53. [PMID: 30477722 DOI: 10.1016/j.jid.2017.03.009] [Reference Citation Analysis]